Performance of models highly depend not only on the used algorithm but also the data set it was applied to. This makes the comparison of newly developed tools to previously published approaches difficult. Either researchers need to implement others' algorithms first, to establish an adequate benchmark on their data, or a direct comparison of new and old techniques is infeasible. The Ischemic Stroke Lesion Segmentation (ISLES) challenge, which has ran now consecutively for 3 years, aims to address this problem of comparability. ISLES 2016 and 2017 focused on lesion outcome prediction after ischemic stroke: By providing a uniformly pre-processed data set, researchers from all over the world could apply their algorithm directly. A total of nine teams participated in ISLES 2015, and 15 teams participated in ISLES 2016. Their performance was evaluated in a fair and transparent way to identify the state-of-the-art among all submissions. Top ranked teams almost always employed deep learning tools, which were predominately convolutional neural networks (CNNs). Despite the great efforts, lesion outcome prediction persists challenging. The annotated data set remains publicly available and new approaches can be compared directly via the online evaluation system, serving as a continuing benchmark (www.isles-challenge.org).
Robot-assisted surgery is an emerging technology which has undergone rapid growth with the development of robotics and imaging systems. Innovations in vision, haptics and accurate movements of robot arms have enabled surgeons to perform precise minimally invasive surgeries. Real-time semantic segmentation of the robotic instruments and tissues is a crucial step in robot-assisted surgery. Accurate and efficient segmentation of the surgical scene not only aids in the identification and tracking of instruments but also provided contextual information about the different tissues and instruments being operated with. For this purpose, we have developed a lightweight cascaded convolutional neural network (CNN) to segment the surgical instruments from high-resolution videos obtained from a commercial robotic system. We propose a multi-resolution feature fusion module (MFF) to fuse the feature maps of different dimensions and channels from the auxiliary and main branch. We also introduce a novel way of combining auxiliary loss and adversarial loss to regularize the segmentation model. Auxiliary loss helps the model to learn low-resolution features, and adversarial loss improves the segmentation prediction by learning higher order structural information. The model also consists of a lightweight spatial pyramid pooling (SPP) unit to aggregate rich contextual information in the intermediate stage. We show that our model surpasses existing algorithms for pixelwise segmentation of surgical instruments in both prediction accuracy and segmentation time of high-resolution videos.
In this work, we develop an attention convolutional neural network (CNN) to segment brain tumors from Magnetic Resonance Images (MRI). Further, we predict the survival rate using various machine learning methods. We adopt a 3D UNet architecture and integrate channel and spatial attention with the decoder network to perform segmentation. For survival prediction, we extract some novel radiomic features based on geometry, location, the shape of the segmented tumor and combine them with clinical information to estimate the survival duration for each patient. We also perform extensive experiments to show the effect of each feature for overall survival (OS) prediction. The experimental results infer that radiomic features such as histogram, location, and shape of the necrosis region and clinical features like age are the most critical parameters to estimate the OS.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.